| Hepatitis Viruses Studies and Epidemiology | Lifetime | 11 | FR 1 | 99.77 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 28 | FR 3 | 99.74 |
| Liver Disease and Transplantation | Lifetime | 57 | FR 7 | 99.76 |
| Viral gastroenteritis research and epidemiology | Lifetime | 155 | FR 5 | 99.35 |
| Hepatitis C virus research | Lifetime | 221 | FR 22 | 99.32 |
| Neurological Complications and Syndromes | Lifetime | 41 | FR 3 | 98.89 |
| Liver Diseases and Immunity | Lifetime | 84 | FR 8 | 99.03 |
| Polyomavirus and related diseases | Lifetime | 99 | FR 7 | 98.70 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 267 | FR 15 | 99.07 |
| Hepatitis B Virus Studies | Lifetime | 349 | FR 24 | 98.99 |
| Cytomegalovirus and herpesvirus research | Lifetime | 347 | FR 11 | 98.35 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 742 | FR 26 | 97.65 |
| Transplantation: Methods and Outcomes | Lifetime | 337 | FR 14 | 98.17 |
| Renal Diseases and Glomerulopathies | Lifetime | 480 | FR 35 | 97.71 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 548 | FR 26 | 97.30 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 851 | FR 35 | 96.46 |
| Pregnancy and Medication Impact | Lifetime | 492 | FR 16 | 95.18 |
| Organ Donation and Transplantation | Lifetime | 677 | FR 19 | 95.63 |
| Erythropoietin and Anemia Treatment | Lifetime | 882 | FR 30 | 89.30 |
| Potassium and Related Disorders | Lifetime | 871 | FR 17 | 86.14 |
| Organ and Tissue Transplantation Research | Lifetime | 990 | FR 34 | 85.43 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 25 | FR 3 | 98.93 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 20 | FR 2 | 97.72 |
| Polyomavirus and related diseases | 2021-2025 | 27 | FR 2 | 98.04 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 543 | FR 18 | 97.80 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 43 | FR 5 | 94.86 |
| Liver Disease and Transplantation | 2021-2025 | 429 | FR 21 | 95.77 |
| Herpesvirus Infections and Treatments | 2021-2025 | 246 | FR 10 | 90.18 |
| Hepatitis B Virus Studies | 2021-2025 | 627 | FR 28 | 90.58 |
| Transplantation: Methods and Outcomes | 2021-2025 | 628 | FR 31 | 89.53 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 847 | FR 39 | 89.76 |
| Renal and Vascular Pathologies | 2021-2025 | 450 | FR 38 | 84.13 |
| Neurological Complications and Syndromes | 2021-2025 | 221 | FR 9 | 77.16 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 906 | FR 42 | 77.38 |
| Parvovirus B19 Infection Studies | 2021-2025 | 499 | FR 41 | 66.28 |
